性与性别少数群体的脑健康结局:来自All of Us研究项目的结果
本研究基于美国All of Us研究项目,纳入393,041名有性取向和性别认同信息的成年人,其中39,632人(10%)属于性与性别少数(SGM)群体。横断面分析显示,SGM群体脑健康复合结局(卒中、痴呆、晚发性抑郁)的比值比高于非SGM个体(OR 1.15,95%CI 1.08-1.22),痴呆和晚发性抑郁的比值比也升高。
要点
- SGM群体脑健康复合结局的OR为1.15(95%CI 1.08-1.22),高于非SGM个体。
- SGM群体痴呆OR为1.14(95%CI 1.00-1.29),晚发性抑郁OR为1.27(95%CI 1.17-1.38)。
- 跨性别女性卒中OR为1.68(95%CI 1.04-2.70)。
核心结论
- 在美国大型人群研究中,SGM个体的脑健康不良结局比值比高于非SGM个体。
- 作者认为进一步研究应探索不公平的结构性原因,以推进包容和多元的神经科诊疗。
研究设计与样本
- 横断面研究,数据来自美国All of Us研究项目。
- 纳入2017年5月31日至2022年6月30日入组的413,457名美国成年人中,有性取向和性别认同信息的393,041人(平均年龄51岁,SD 17)。
- 其中39,632人(10%)属于SGM群体;38,528人(97%)属于性少数,4,431人(11%)属于性别少数。
- 采用多变量逻辑回归,调整年龄、出生指定性别、种族/族裔、心血管危险因素、其他相关合并症和社区剥夺指数。
主要发现
- SGM个体脑健康复合结局(卒中、痴呆、晚发性抑郁)的OR为1.15(95%CI 1.08-1.22),高于非SGM个体。
- 性少数和性别少数分别分析时,结果持续存在(所有95%CI均大于1)。
- SGM个体痴呆OR为1.14(95%CI 1.00-1.29),晚发性抑郁OR为1.27(95%CI 1.17-1.38),均高于非SGM个体。
- 跨性别女性卒中OR为1.68(95%CI 1.04-2.70)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Sexual and gender minority (SGM) groups have been historically underrepresented in neurologic research, and their brain health disparities are unknown. We aim to evaluate whether SGM persons are at higher risk of adverse brain health outcomes compared with cisgender straight (non-SGM) individuals. METHODS: We conducted a cross-sectional study in the All of Us Research Program, a US population-based study, including all participants with information on gender identity and sexual orientation. We used baseline questionnaires to identify sexual minority (lesbian, gay, bisexual, diverse sexual orientation; nonstraight sexual orientation) and gender minority (gender diverse and transgender; gender identity different from sex assigned at birth) participants. The primary outcome was a composite of stroke, dementia, and late-life depression, assessed using electronic health record data and self-report. Secondarily, we evaluated each disease separately. Furthermore, we evaluated all subgroups of gender and sexual minorities stratified by sex assigned at birth. We used multivariable logistic regression (adjusted for age, sex assigned at birth, race/ethnicity, cardiovascular risk factors, other relevant comorbidities, and neighborhood deprivation index) to assess the relationship between SGM groups and the outcomes. RESULTS: Of 413,457 US adults enrolled between May 31, 2017, and June 30, 2022, we included 393,041 participants with available information on sexual orientation and gender identity (mean age 51 [SD 17] years), of whom 39,632 (10%) belonged to SGM groups. Of them, 38,528 (97%) belonged to a sexual minority and 4,431 (11%) to a gender minority. Compared with non-SGM, SGM persons had 15% higher odds of the brain health composite outcome (odds ratio [OR] 1.15, 95% CI 1.08-1.22). In secondary analyses, these results persisted across sexual and gender minorities separately (all 95% CIs > 1). Assessing individual diseases, all SGM groups had higher odds of dementia (SGM vs non-SGM: OR 1.14, 95% CI 1.00-1.29) and late-life depression (SGM vs non-SGM: OR 1.27, 95% CI 1.17-1.38) and transgender women had higher odds of stroke (OR 1.68, 95% CI 1.04-2.70). DISCUSSION: In a large US population study, SGM persons had higher odds of adverse brain health outcomes. Further research should explore structural causes of inequity to advance inclusive and diverse neurologic care.
引用
- Huo S, Rivier CA, Clocchiatti-Tuozzo S, et al. Brain Health Outcomes in Sexual and Gender Minority Groups: Results From the All of Us Research Program. Neurology. 2024. PMID: 39321407. doi:10.1212/WNL.0000000000209863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。